Fulminant acute hepatitis b after infliximab in Crohn’s disease

##plugins.themes.academic_pro.article.sidebar##

Published Sep 16, 2014
Download
pdf
Vol. 92 No. 5 (2014): Issue May 2014

##plugins.themes.academic_pro.article.main##

Olfa Hellara
Aroua Gueddiche
Aya Hammami
Wissem Melki
Wafa Ben Mansour
Hichem Loghmari
Nabil Ben Chaabène
Fethia BDIOUI
Leila Safer
Hammouda Saffar

##plugins.themes.academic_pro.article.details##

References

  1. Gunda Millonig, Michaela Kern, Othmar Ludwig, Karin Nachbaur, Wolfgang Vogel. Subfulimanant hepatitis B after infliximab in crohn's disease: Need for HBV-screening? World J Gastroenterol 2006;12:974-6.
  2. Pérez Alvarez R, Diaz Lagares C, Garcia Hermà ndez F, Lopez-Roses L, Brito- Zron P, Pérez-de-Lis M et al. Hepatitis B virus réactivation receiving in patints receiving tumor necrosis factor -targeted therapy: anlysis of 257 cases.Medecine 2011;6:359-71.
  3. Debbie M Nathan, Peter W Angus and Peter R Gibson. Hepatitis B and C virus infections and anti-tumor necrosis factor-α therapy: Guidelines for clinical approach. Journal of Gastroenterology and Hepatology 2006;21:1366-71.